Select Page

STIVARGA (regorafenib) tablets, oral. Initial U.S. Approval: 2012

STIVARGA (regorafenib) tablets, oral. Initial U.S. Approval: 2012

STIVARGA (regorafenib) tablets is a prescription medicine. STIVARGA (regorafenib) tablets is used for metastatic colorectal cancer (CRC).
INDICATIONS AND USAGE
Stivarga is a kinase inhibitor indicated for the treatment of patients with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an antiVEGF therapy, and, if KRAS wild type, an anti-EGFR therapy.
DOSAGE FORMS & STRENGTHS
40 mg film-coated tablets
Manufactured By: Bayer HealthCare Pharmaceuticals Inc
Prescribing Information URL: Click Here

Procedure to buy STIVARGA (regorafenib) tablets tablets?
To buy STIVARGA (regorafenib) tablets tablets, patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

Categories: ,

Regorafenib, sold under the brand name Stivarga among others, is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition.

Metastatic colorectal cancer
Regorafenib demonstrated to increase the overall survival of patients with metastatic colorectal cancer and has been approved by the US FDA on September 27, 2012.

Advanced gastrointestinal stromal tumours
On February 25, 2013 the US FDA expanded the approved use to treat patients with advanced gastrointestinal stromal tumors that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.

Advanced hepatocellular carcinoma
On November 29, 2018 the National Institute for Health and Care Excellence (NICE) approved use of regorafenib in patients with advanced hepatocellular carcinoma who were previously treated with sorafenib.

 

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

STIVARGA (regorafenib) tablets in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
STIVARGA (regorafenib) tablets in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
STIVARGA (regorafenib) tablets in North America – Mexico.
STIVARGA (regorafenib) tablets in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
STIVARGA (regorafenib) tablets in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
STIVARGA (regorafenib) tablets in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
STIVARGA (regorafenib) tablets in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
STIVARGA (regorafenib) tablets in Australia and New Zealand.

For Indian Patient

Ani-Cancer STIVARGA (regorafenib) tablets are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

STIVARGA (regorafenib) tablets can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

Reviews

There are no reviews yet.

Be the first to review “STIVARGA (regorafenib) tablets, oral. Initial U.S. Approval: 2012”

Your email address will not be published.

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.